A multicenter, randomized, open-label, parallel design trial to compare time to response in the symptoms of anxiety to concomitant treatment with Niravam [alprazolam] and an SSRI [selective serotonin reuptake inhibitor] or SNRI [selective norepinephrine reuptake inhibitor] to treatment with an SSRI or SNRI alone in subjects with generalized anxiety disorder or panic disorder.

Trial Profile

A multicenter, randomized, open-label, parallel design trial to compare time to response in the symptoms of anxiety to concomitant treatment with Niravam [alprazolam] and an SSRI [selective serotonin reuptake inhibitor] or SNRI [selective norepinephrine reuptake inhibitor] to treatment with an SSRI or SNRI alone in subjects with generalized anxiety disorder or panic disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2015

At a glance

  • Drugs Alprazolam (Primary) ; Adrenergic receptor antagonists; Serotonin uptake inhibitors
  • Indications Generalised anxiety disorder; Panic disorder
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 06 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top